Cited by 18Parasitic Diseases Research and TreatmentHelminth infection and controlResearch on Leishmaniasis Studies

Evaluation of the Therapeutic and Preventive Efficacy of 2.5 % Moxidectin / 10 % Imidacloprid (Advocate®, Bayer Animal Health) in Dogs Naturally Infected or at Risk of Natural Infection by Dirofilaria repens

Open access
Hellmann, Klaus, Heine, Josef, Braun, Gabriele, Paran-Dobesova, Radmila, Svobodova, Vlasta·2011·Parasitology Research

Abstract

The objective of this GCP-compliant clinical field study was to evaluate the efficacy of the combination of moxidectin (minimum dose of 2.5 mg/kg body weight) and imidacloprid (minimum dose of 10.0 mg/kg body weight) spot-on (Advocate(®)) as a preventive and therapeutic treatment of natural infection by Dirofilaria repens in dogs in the Czech Republic.There were two arms of the study, both negatively controlled. 34 animals were randomly allocated to two groups of the treatment arm; 90 negative animals were randomly allocated to the prevention arm groups. All enrolled dogs were observed physically and blood was sampled monthly for Dirofilaria repens microfilaria counts for 18 months by modified Knott test and PCR. 34 dogs were positive for microfilaria and enrolled in the treatment arm of this study (treated: 18, untreated: 16). The reduction of the log-transformed microfilaria counts was significantly higher in the treatment group on day 28 (p = 0.007), 56, 84 and 112 (p < 0.001). All animals treated were negative after a single treatment. In the untreated control group 93.75 % remained positive (p < 0.001). 87 dogs were negative for microfilaria prior to allocation to the "preventive" arm (treated: 49; untreated: 38; 3 excluded). One dog in the untreated control group became positive for Dirofliaria repens microfilaria, while none of the treated dogs became positive. Advocate(®) was effective in the treatment of dogs infected with microfilaria of Dirofilaria repens. Due to the low rate of natural infections the preventive efficacy could not be proven, but no dog treated became positive.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00436-011-2404-6

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Moxidectin showed a high degree of efficacy in treating Dirofilaria repens infection, including potential ability to kill adults, after a single administration.

    “The latter molecule also showed a high degree of efficacy in treating D. repens infection, including potential ability to kill adults, after a single administration [112-114].”

    From Vector-borne helminths of dogs and humans in Europe (2013) · cites this paper as [114]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Genchi C, Poglayen G, Kramer L, Casiraghi M, Venco L, Bri- anti E (2002) Efficacy of selamectin in the prophylaxis of Diro- filaria repens infestations in dogs. Veterinaria 16(1):69 -71.
  2. Kershaw O, Dyachenko V, Gruber AD (2009) Kutane Diro- filariose beim Hund in Deutschland. Dtsch Tierärztl Wochen- schr 116(7):273.
  3. Vasylyk NS (2004) Morhological and functional changes and adaptations and compensatory reactions in dog's organism at dirofilariosis. Dissertation, National Agrarian University, Kiew, pp 1 -22. VICH guideline 7: Efficacy requirements for anthelmintics, overall requirements (Step 7, CVMP/VICH/832/99-corr) 1999. VICH guideline 9: Good clinical practice (CVMP/VICH/595/98 -Final) 2000. VICH guideline 19: Efficacy of anthelmintics: specific recom- mendations for canines (Step 7, CVMP/VICH/835/99 -Final) 1999.

Cited by

Sorted by citations

Authors
Hellmann, K., Heine, J., Braun, G., Paran-Dobesova, R., & Svobodova, V.
Affiliations
Elanco Animal Health (Germany) (DE)
Corresponding author
Hellmann, Klaus
Venue
Parasitology Research
Published
2011-07-08
Volume
109
Issue
S1
Pages
77-86
ISSN
  • 0044-3255 (ISSN-L)
  • 0932-0113
  • 1432-1955
OpenAlex
W2055544124
Cited by
18
References
23
Citations by year
2022: 1 · 2020: 1 · 2018: 1 · 2016: 3 · 2015: 6 · 2014: 1 · 2013: 3 · 2012: 1
FWCI
1.29
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Parasitology Research (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Bayer Animal Health
Topics
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
  • Health Sciences › Veterinary › Small Animals › Helminth infection and control
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
Keywords
moxidectin, imidacloprid, Dirofilaria repens, canine heartworm disease, treatment efficacy, prophylaxis efficacy, dogs
MeSH terms
Neonicotinoids, Animals, Dirofilaria, Dirofilariasis, Dog Diseases, Dogs, Drug Combinations, Drug Evaluation, Filaricides, Imidazoles, Nitro Compounds, Macrolides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review